Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: IMMUNE CHECKPOINT INHIBITOR THERAPY, . Treffer: 6
2023
Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1):
Doi: 10.3390/ijms24010818
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083
Doi: 10.1002/cam4.4675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207
Doi: 10.3389/fimmu.2022.840207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Moik, F; Chan, WE; Wiedemann, S; Hoeller, C; Tuchmann, F; Aretin, MB; Fuereder, T; Zöchbauer-Müller, S; Preusser, M; Pabinger, I; Ay, C
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Blood. 2021; 137(12):1669-1678
Doi: 10.1182/blood.2020007878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Veatch, JR; Lee, SM; Fitzgibbon, M; Chow, IT; Jesernig, B; Schmitt, T; Kong, YY; Kargl, J; Houghton, AM; Thompson, JA; McIntosh, M; Kwok, WW; Riddell, SR
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.
J CLIN INVEST. 2018; 128(4): 1563-1568.
Doi: 10.1172/JCI98689
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Kargl, J; Busch, SE; Yang, GH; Kim, KH; Hanke, ML; Metz, HE; Hubbard, JJ; Lee, SM; Madtes, DK; McIntosh, MW; Houghton, AM
Neutrophils dominate the immune cell composition in non-small cell lung cancer.
Nat Commun. 2017; 8(5):14381-14381
Doi: 10.1038/ncomms14381
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG